BARR BODY DISTRIBUTION AND ESTROGEN-RECEPTOR PROTEIN IN MAMMARY-CARCINOMA
- 1 January 1977
- journal article
- research article
- Vol. 7 (6) , 491-499
Abstract
This study was undertaken to investigate the relationship between Barr body distribution and estrogen receptor protein [ERP] content of mammary carcinoma. The proportion of cells with 1 or more Barr body was determined in 105 specimens of mammary carcinoma from Guard stained imprints. Receptor protein content of the specimen was measured by the dextran charcoal method and compared with histopathologic features of the carcinomas. Primary carcinomas with Barr bodies in more than 10% of tumor cells were more likely to have higher levels of receptor protein than those with a lower proportion of Barr body containing cells (P < 0.005). The results obtained for primary carcinoma may explain why patients with carcinomas that have a high proportion of Barr body positive cells are more likely to respond to hormonal therapy. These observations, when correlated with other available data about ERP suggest that an X-chromosome is involved in the synthesis of and/or carries the locus of action for estrogen receptor protein.This publication has 6 references indexed in Scilit:
- Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancerCancer, 1977
- Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue.Clinical Chemistry, 1976
- Value of Genetic Variants of Glucose-6-Phosphate Dehydrogenase in Tracing the Origin of Malignant TumorsNew England Journal of Medicine, 1967
- Sex chromatin incidence and prognosis in breast cancerCancer, 1966
- Clinical-cytological correlations of mammary carcinoma based upon sex-chromatin countsA Preliminary StudyCancer, 1957
- A Morphological Distinction between Neurones of the Male and Female, and the Behaviour of the Nucleolar Satellite during Accelerated Nucleoprotein SynthesisNature, 1949